An additional human chromosome 21 causes suppression of neural fate of pluripotent mouse embryonic stem cells in a teratoma model

BMC Developmental Biology

Volumn 7, Issue , 2007, Pages

  Mensah, Afua ^a   Mulligan, Claire ^a   Linehan, Jackie ^b   Ruf, Sandra ^c   O'Doherty, Aideen ^b   Grygalewicz, Beata ^d   Shipley, Janet ^d   Groet, Juergen ^a   Tybulewicz, Victor ^c   Fisher, Elizabeth ^b   Brandner, Sebastian ^b   Nizetic, Dean ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; NEURON SPECIFIC NUCLEAR PROTEIN; TUBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CHROMOSOME 21; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; GENE REPRESSION; HUMAN CHROMOSOME; MOUSE; NERVE CELL; NEUROECTODERM; NONHUMAN; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; TERATOMA; TRISOMY; ANIMAL; ASTROCYTE; CELL LINE; EXPERIMENTAL NEOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA; MUS;

ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; CELL LINE; CHROMOSOMES, HUMAN, PAIR 21; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MICE; NEOPLASMS, EXPERIMENTAL; NEURAL PLATE; NEURONS; PLURIPOTENT STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TERATOMA; TUBULIN;

EID: 38349120034     PISSN: None     EISSN: 1471213X     Source Type: Journal    
DOI: 10.1186/1471-213X-7-131     Document Type: Article

References (34)

1. Chromosome 21 and down syndrome: from genomics to pathophysiology. SE Antonarakis R Lyle ET Dermitzakis A Reymond S Deutsch, Nat Rev Genet 2004 5 725 738 10.1038/nrg1448 15510164
2. Down Syndrome. C Epstein, The metabolic and molecular bases of inherited disease New York, McGraw-Hill, Scriver CR BALSWSVD, 2001 1223 1256
3. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Q Yang SA Rasmussen JM Friedman, Lancet 2002 359 1019 1025 10.1016/S0140-6736(02)08092-3 11937181
4. Cerebral morphologic distinctions between Williams and Down syndromes. TL Jernigan U Bellugi E Sowell S Doherty JR Hesselink, Arch Neurol 1993 50 186 191 8431138
5. Down syndrome in neurobiological perspective. L Nadel, Neurodevelopmental disorders Cambridge MA, MIT Press, Tager-Flusberg H, 1999 197 221
6. Neuroanatomy of Down's syndrome: a high-resolution MRI study. JD Pinter S Eliez JE Schmitt GT Capone AL Reiss, Am J Psychiatry 2001 158 1659 1665 10.1176/appi.ajp.158.10.1659 11578999
7. Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. S Bahn M Mimmack M Ryan MA Caldwell E Jauniaux M Starkey CN Svendsen P Emson, Lancet 2002 359 310 315 10.1016/S0140-6736(02)07497-4 11830198
8. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. J Busciglio BA Yankner, Nature 1995 378 776 779 10.1038/378776a0 8524410
9. A lack of neuroblastoma in Down syndrome: a study from 11 European countries. D Satge AJ Sasco NL Carlsen CA Stiller H Rubie B Hero B de Bernardi J de Kraker C Coze P Kogner F Langmark FG Hakvoort-Cammel D Beck N von der Weid S Parkes O Hartmann RJ Lippens WA Kamps D Sommelet, Cancer Res 1998 58 448 452 9458088
10. Risks of leukaemia and solid tumours in individuals with Down's syndrome. H Hasle IH Clemmensen M Mikkelsen, Lancet 2000 355 165 169 10.1016/S0140- 6736(99)05264-2 10675114
11. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. LL Baxter TH Moran JT Richtsmeier J Troncoso RH Reeves, Hum Mol Genet 2000 9 195 202 10.1093/hmg/9.2.195 10607830
12. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. H Sago EJ Carlson DJ Smith J Kilbridge EM Rubin WC Mobley CJ Epstein TT Huang, Proc Natl Acad Sci U S A 1998 95 6256 6261 9600952 10.1073/pnas.95.11.6256
13. Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome. RJ Siarey AJ Villar CJ Epstein Z Galdzicki, Neuropharmacology 2005 49 122 128 10.1016/j.neuropharm.2005.02.012 15992587
14. Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutaze and amyloid precursor protein. C Harris-Cerruti A Kamsler B Kaplan B Lamb M Segal Y Groner, Eur J Neurosci 2004 19 1174 1190 10.1111/j.1460-9568.2004.03188.x 15016076
15. Defective cerebellar response to mitogenic Hedgehog signaling in Down's syndrome mice. RJ Roper LL Baxter NG Saran DK Klinedinst PA Beachy RH Reeves, Proc Natl Acad Sci U S A 2006 103 1452 1456 16432181 10.1073/pnas.0510750103
16. Hippocampal hypocellularity in the Ts65Dn mouse originates early in development. HA Lorenzi RH Reeves, Brain Res 2006 1104 153 159 10.1016/j.brainres.2006.05.022 16828061
17. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. JD Cooper A Salehi JD Delcroix CL Howe PV Belichenko J Chua-Couzens JF Kilbridge EJ Carlson CJ Epstein WC Mobley, Proc Natl Acad Sci U S A 2001 98 10439 10444 11504920 10.1073/pnas.181219298
18. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. A Salehi JD Delcroix PV Belichenko K Zhan C Wu JS Valletta R Takimoto-Kimura AM Kleschevnikov K Sambamurti PP Chung W Xia A Villar WA Campbell LS Kulnane RA Nixon BT Lamb CJ Epstein GB Stokin LS Goldstein WC Mobley, Neuron 2006 51 29 42 10.1016/j.neuron.2006.05.022 16815330
19. Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of Down syndrome. AM Insausti M Megias D Crespo LM Cruz-Orive M Dierssen IF Vallina R Insausti J Florez, Neurosci Lett 1998 253 175 178 10.1016/S0304-3940(98) 00641-7 9792239
20. Prenatal losses of trisomy 21. J Boue C Deluchat H Nicolas A Boue, Hum Genet Suppl 1981 2 183 193 6218135
21. To err (meiotically) is human: the genesis of human aneuploidy. T Hassold P Hunt, Nat Rev Genet 2001 2 280 291 10.1038/35066065 11283700
22. Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. T Shinohara K Tomizuka S Miyabara S Takehara Y Kazuki J Inoue M Katoh H Nakane A Iino A Ohguma S Ikegami K Inokuchi I Ishida RH Reeves M Oshimura, Hum Mol Genet 2001 10 1163 1175 10.1093/hmg/10.11.1163 11371509
23. An aneuploid mouse strain carrying human chromosome 21 with down syndrome phenotypes. A O'Doherty S Ruf C Mulligan V Hildreth ML Errington S Cooke A Sesay S Modino L Vanes D Hernandez JM Linehan PT Sharpe S Brandner TV Bliss DJ Henderson D Nizetic VL Tybulewicz EM Fisher, Science 2005 309 2033 2037 16179473 10.1126/science.1114535
24. Transchromosomal mouse embryonic stem cell lines and chimeric mice that contain freely segregating segments of human chromosome 21. D Hernandez PJ Mee JE Martin VL Tybulewicz EM Fisher, Hum Mol Genet 1999 8 923 933 10.1093/hmg/8.5.923 10196383
25. Adult neurogenesis in the mammalian central nervous system. GL Ming H Song, Annu Rev Neurosci 2005 28 223 250 10.1146/annurev.neuro.28.051804.101459 16022595
26. Neurogenesis in the adult hippocampus. BR Christie HA Cameron, Hippocampus 2006 16 199 207 10.1002/hipo.20151 16411231
27. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. LE Olson RJ Roper LL Baxter EJ Carlson CJ Epstein RH Reeves, Dev Dyn 2004 230 581 589 10.1002/dvdy.20079 15188443
28. Trisomy for the Down syndrome "critical region" is necessary but not sufficient for brain phenotypes of trisomic mice. LE Olson RJ Roper CL Sengstaken EA Peterson V Aquino Z Galdzicki R Siarey M Pletnikov TH Moran RH Reeves, Hum Mol Genet 2007
29. Familial 4.3Mb duplication of 21q22 sheds new light on the Down Syndrome Critical Region. A Ronan K Fagan L Christie J Conroy N Nowak G Turner, J Med Genet 2007 17237124
30. Interphase fluorescence in situ hybridization detection of t(2;13)(q35;q14) in alveolar rhabdomyosarcoma - a diagnostic tool in minimally invasive biopsies. AP McManus MA O'Reilly KP Jones BA Gusterson CD Mitchell CR Pinkerton JM Shipley, J Pathol 1996 178 410 414 10.1002/(SICI)1096-9896(199604) 178:4<410::AID-PATH508>3.0.CO;2-A 8691319
31. UniSTS database. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=unists
32. Unigene database. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db= unigene
33. Human chromosome 21 gene expression atlas in the mouse. A Reymond V Marigo MB Yaylaoglu A Leoni C Ucla N Scamuffa C Caccioppoli ET Dermitzakis R Lyle S Banfi G Eichele SE Antonarakis A Ballabio, Nature 2002 420 582 586 10.1038/nature01178 12466854
34. A gene expression map of human chromosome 21 orthologues in the mouse. Y Gitton N Dahmane S Baik A Ruiz i Altaba L Neidhardt M Scholze BG Herrmann P Kahlem A Benkahla S Schrinner R Yildirimman R Herwig H Lehrach ML Yaspo, Nature 2002 420 586 590 10.1038/nature01270 12466855